Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (4)
P 3 (1)
P 4 (1)

Trial Status

Recruiting11
Unknown8
Completed2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT06251778Recruiting

NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

NCT07172243Recruiting

BE.Amycon Biobank & Data Registry UZ Leuven

NCT07359690Recruiting

Multimodal Analysis of Endomyocardial Biopsies

NCT07314268Recruiting

ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers

NCT07112066Not ApplicableRecruitingPrimary

Multimodality Cardiac Imaging for Disease Progression in ATTR-CM

NCT04667494Phase 4RecruitingPrimary

Ultrasound Therapy In Cardiac Amyloidosis

NCT06887283Recruiting

Essen Amyloidosis Registry

NCT05379101RecruitingPrimary

Intracardiac Flow Assessment in Cardiac Amyloidosis

NCT05489549Recruiting

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

NCT06813443Recruiting

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

NCT04587648Recruiting

Cardiac Amyloidosis in HFpEF

NCT04298372Phase 3CompletedPrimary

Frontline Lenalidomide for AL Amyloidosis Involving Myocardium

NCT06186167Unknown

Amyloidosis Incidence in High-Risk Cardiac Device Patients

NCT06066632UnknownPrimary

Analysis of Calcium Score of Severe Aortic Stenosis in Patients With and Without Cardiac Amyloidosis (CAUSATIVE Study)

NCT05938218Not ApplicableUnknownPrimary

Virtual Reality Assisted Patient Empowerment: Diagnose ATTR-Amyloidosis And Start Treatment

NCT05718401Unknown

The Diagnostic Pattern and Prognosis of Multiple Myeloma Patients With Myocardial Amyloidosis Were Evaluated by NMR Based Metabolomics

NCT04061213Unknown

ATTR Amyloidosis in Elderly Patients With Aortic Stenosis

NCT05167799UnknownPrimary

Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure

NCT03996382Not ApplicableCompletedPrimary

Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome

NCT04985734Not ApplicableUnknownPrimary

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Patients With Idiopathic Peripheral Neuropathy

Scroll to load more

Research Network

Activity Timeline